Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Allergan Plc (AGN)

Allergan Plc (AGN)
193.02 +0.03 (+0.02%) 05/09/20 [NYSE]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Fri, May 8th, 2020
Day Low
191.64
Day High
193.38
Open 193.01
Previous Close 192.99 192.99
Volume 12,442,600 12,442,600
Avg Vol 4,993,145 4,993,145
Stochastic %K 74.82% 74.82%
Weighted Alpha +28.20 +28.20
5-Day Change +3.28 (+1.73%) +3.28 (+1.73%)
52-Week Range 114.27 - 202.21 114.27 - 202.21
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,503,972
  • Shares Outstanding, K 329,002
  • Annual Sales, $ 16,089 M
  • Annual Income, $ -5,271 M
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.20
  • Price/Sales 3.95
  • Price/Cash Flow 5.26
  • Price/Book 1.09
  • Price/Earnings ttm 10.94
  • Earnings Per Share ttm 17.64
  • Most Recent Earnings $5.22 on 02/10/20
  • Next Earnings Date 05/07/20
  • Annual Dividend & Yield 2.96 (1.53%)
  • Most Recent Dividend 0.740 on 04/15/20
  • Sector Medical
  • INDUSTRY GROUPING Medical - Generic Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 4.24
  • Number of Estimates 1
  • High Estimate 4.24
  • Low Estimate 4.24
  • Prior Year 3.79
  • Growth Rate Est. (year over year) +11.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
181.21 +6.52%
on 04/09/20
Period Open: 181.08
196.45 -1.75%
on 05/06/20
+11.94 (+6.59%)
since 04/08/20
3-Month
158.67 +21.65%
on 03/18/20
Period Open: 197.05
202.21 -4.55%
on 02/12/20
-4.03 (-2.05%)
since 02/07/20
52-Week
114.27 +68.92%
on 06/17/19
Period Open: 140.05
202.21 -4.55%
on 02/12/20
+52.97 (+37.82%)
since 05/08/19

Most Recent Stories

More News
Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now

Teva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp?

CVS : 64.38 (+1.13%)
NVO : 63.78 (+1.97%)
JNJ : 150.95 (-1.49%)
WBA : 10.68 (-0.09%)
AGN : 193.02 (+0.02%)
TEVA : 13.91 (+0.80%)
Virios Therapeutics Up 75% on Fibromyalgia Phase 3 Proposal

Virios Therapeutics Inc. (NASDAQ: VIRI) is a developmental-stage biotechnology company specializing in novel antiviral therapies for treating fibromyalgia

VIRI : 0.1550 (+12.40%)
AGN : 193.02 (+0.02%)
LLY : 723.90 (-1.94%)
PFE : 22.64 (-1.44%)
GPS : 24.55 (+4.38%)
Is the Pain Over for Baudax Bio Investors after a 70% Spike?

Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000.

BXRX : 0.0218 (+7.39%)
ABBV : 186.17 (-0.42%)
PFE : 22.64 (-1.44%)
AGN : 193.02 (+0.02%)
MRK : 81.35 (-0.15%)
Aegon NV: Q3 Earnings Snapshot

Aegon NV: Q3 Earnings Snapshot

AGN : 193.02 (+0.02%)
AEG : 5.55 (-3.48%)
Judge: Walgreens contributed to San Francisco opioid crisis

SAN FRANCISCO (AP) — A federal judge ruled Wednesday that Walgreens can be held responsible for contributing to San Francisco's opioid crisis for over-dispensing highly addictive drugs for years without...

AGN : 193.02 (+0.02%)
States reach deal over marketing, safety of generic opioids

HARRISBURG, Pa. (AP) — A former opioid manufacturer has agreed in principle to pay up to $2.4 billion in a deal with a dozen states over its marketing and product safety practices, state attorneys general...

MCK : 668.93 (-2.08%)
CAH : 127.01 (-2.02%)
AGN : 193.02 (+0.02%)
JNJ : 150.95 (-1.49%)
WVa opioid trial verdict still pending nearly a year later

CHARLESTON, W.Va. (AP) — Last July, a federal judge in West Virginia in the first lawsuit to go to trial over the U.S. opioid addiction epidemic.

MCK : 668.93 (-2.08%)
CAH : 127.01 (-2.02%)
AGN : 193.02 (+0.02%)
Tentative $161.5M settlement reached in WVa opioid trial

CHARLESTON, W.Va. (AP) — Attorneys for the state of West Virginia and two remaining pharmaceutical manufacturers have reached a tentative $161.5 million settlement just as closing arguments were set...

MCK : 668.93 (-2.08%)
CAH : 127.01 (-2.02%)
JNJ : 150.95 (-1.49%)
AGN : 193.02 (+0.02%)
Walgreens, Florida settle opioid costs lawsuit for $683M

ST. PETERSBURG, Fla. (AP) — The Walgreens pharmacy chain has reached a $683 million settlement with the state of Florida in a lawsuit accusing the company of improperly dispensing millions of painkillers...

AGN : 193.02 (+0.02%)
CAH : 127.01 (-2.02%)
1 drug company settles ahead of San Francisco opioid trial

SAN FRANCISCO (AP) — Drugmaker Endo Pharmaceuticals has agreed to pay the city of San Francisco $10 million over its role in selling prescription opioids in the city.

AGN : 193.02 (+0.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 194.42
1st Resistance Point 193.72
Last Price 193.02
1st Support Level 191.98
2nd Support Level 190.94
3rd Support Level N/A

See More

52-Week High 202.21
Last Price 193.02
Fibonacci 61.8% 168.62
Fibonacci 50% 158.24
Fibonacci 38.2% 147.86
52-Week Low 114.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades